Filter
161
Text search:
AmC
Featured
Recommendations
15
New Publications
26
Language
Document type
Studies & Reports
55
No document type
40
Guidelines
25
Strategic & Response Plan
14
Manuals
11
Fact sheets
8
Training Material
5
Resource Platforms
2
Situation Updates
1
Countries / Regions
India
20
Latin America and the Carribbean
5
Global
5
Burkina Faso
4
Kenya
4
Brazil
4
West and Central Africa
4
Cameroon
3
Uganda
3
Zambia
3
Malawi
3
East and Southern Africa
3
Africa
3
Senegal
2
Mali
2
Guinea-Bissau
2
Ethiopia
2
Ghana
2
Germany
2
Tanzania
2
Bangladesh
2
Mozambique
2
Colombia
2
Angola
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Western and Central Europe
2
Paraguay
2
Tajikistan
2
Russia
2
Gabon
2
Sierra Leone
1
Nigeria
1
Niger
1
Zimbabwe
1
Philippines
1
Afghanistan
1
Syria
1
Chad
1
Mauritania
1
Sudan
1
Argentina
1
Eswatini/ Swaziland
1
North Macedonia
1
Serbia
1
Bolivia
1
Yemen
1
South–East Asia Region
1
Bhutan
1
Armenia
1
Laos
1
Timor Leste/ East Timor
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
Georgia
1
North America
1
Turkmenistan
1
Authors & Publishers
Publication Years
Category
Countries
77
Women & Child Health
4
Capacity Building
3
Clinical Guidelines
2
Key Resources
1
Pharmacy & Technologies
1
Toolboxes
AMR
49
COVID-19
32
Pharmacy
9
Health Financing Toolbox
6
NTDs
5
HIV
4
TB
4
Planetary Health
4
Global Health Education
3
Disability
1
Ebola
1
Rapid Response
1
Refugee
1
Mental Health
1
Caregiver
1
NCDs
1
During the COVID-19 health crisis, community pharmacists had an enhanced role in supporting health-care systems that were overburdened by managing seriously ill patients. This study was undertaken to determine the patterns of community supply of antiviral and antibacterial agents from community phar
...
Objetivo general: Delinear las recomendaciones para la atención médica de niños, adolescentes y adultos infectados por el T. cruzi, en cualquiera de sus fases y formas clínicas. Se espera de esta forma optimizar el uso de recursos y mejorar la calidad de atención de los pacientes, con el fin de
...
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has
...
This Tailoring Antimicrobial Resistance Programmes (TAP) process assists Member States in initiating and undertaking projects to address the spread of antimicrobial resistance (AMR) in their countries. AMR is a complex problem requiring unique, context-specific solutions. This TAP Toolbo
...
Guía de Práctica Clínica para el manejo de la hipertensión arterial primaria (HTA)
Objetivo: Describir el perfil de sensibilidad y resistencia antimicrobiana de las bacterias “ESKAPE” aisladas en todas las unidades de internación del Hospital Del Norte durante la gestión 2019.
This policy brief aims to provide a review of the current progress on implementing the Malawi national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing a
...
31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.
Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s set-up and ways of working, to ensure countries co
...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future
...
This policy brief aims to provide a review of the current progress on implementing the Kenya national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing ac
...
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of information concerning the chronic phase of human Chaga
...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r
...
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the
...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po
...
Mali national action plan on antimicrobial resistance: review of progress in the human health sector
This policy brief aims to provide a review of the current progress on implementing the Mali national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing act
...
Taenia saginata is a zoonotic tapeworm that is of economic importance in countries where cattle are kept. The parasite is transmitted from human tapeworm carriers (taeniosis) to bovines (cysticercosis) by excretion of eggs or proglottids containing eggs into the environment via the stool. Bovines ca
...
In the last decade, Timor-Leste has made remarkable progress in strengthening its health system and improving the health status of its population. This has resulted in an increased life expectancy, and the achievement of Millennium Development Goals such as a reduction in infant and under-five morta
...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o
...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm
...
The annual Development Co-operation Report brings new evidence, analysis and ideas on
sustainable development to members of the OECD Development Assistance Committee (DAC) and the international community more broadly. The objectives are to promote best practices and innovation in development co-ope
...
